Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,481,550
  • Shares Outstanding, K 29,050
  • Annual Sales, $ 0 K
  • Annual Income, $ -70,430 K
  • 36-Month Beta 2.15
  • Price/Sales 168.87
  • Price/Cash Flow N/A
  • Price/Book 10.74

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.80 +20.20%
on 06/28/18
58.28 -5.53%
on 07/20/18
+3.55 (+6.89%)
since 06/20/18
3-Month
26.00 +111.73%
on 04/25/18
58.28 -5.53%
on 07/20/18
+25.80 (+88.21%)
since 04/20/18
52-Week
4.45 +1,137.08%
on 08/03/17
58.28 -5.53%
on 07/20/18
+50.40 (+1,083.87%)
since 07/20/17

Most Recent Stories

More News
Watch for Mirati Therapeut to Potentially Pullback After Gaining 11.44% Yesterday

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $50.90 to a high of $58.28. Yesterday, the shares gained 11.4%, which took the trading range above the 3-day high...

MRTX : 55.05 (+7.94%)
Shares of MRTX Up 55.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on April 17th, 2018 at $31.65. In approximately 3 months, Mirati Therapeut has returned 55.61% as of today's recent price of $49.25.

MRTX : 55.05 (+7.94%)
Mirati Therapeut Set to Possibly Rebound After Yesterday's Selloff of 5.58%

Mirati Therapeut (NASDAQ:MRTX) traded in a range yesterday that spanned from a low of $49.55 to a high of $52.70. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of...

MRTX : 55.05 (+7.94%)
Mirati Therapeut Shares Up 67.0% Since SmarTrend's Buy Recommendation (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on April 17th, 2018 at $31.65. In approximately 3 months, Mirati Therapeut has returned 66.98% as of today's recent price of $52.85.

MRTX : 55.05 (+7.94%)
Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?

Style Box ETF report for DWAS

AXGN : 55.00 (-0.36%)
DWAS : 56.63 (-0.42%)
MGPI : 91.93 (+0.21%)
MRTX : 55.05 (+7.94%)
51.8% Return Seen to Date on SmarTrend Mirati Therapeut Call (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on April 17th, 2018 at $31.65. In approximately 3 months, Mirati Therapeut has returned 51.82% as of today's recent price of $48.05.

MRTX : 55.05 (+7.94%)
Mirati Therapeutics Added to Russell 2000® Index

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that it has been added to the Russell 2000® Index, effective as of the open of the market on Monday,...

MRTX : 55.05 (+7.94%)
Mirati Therapeut Shares Up 60.8% Since SmarTrend's Buy Recommendation (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on April 17th, 2018 at $31.65. In approximately 2 months, Mirati Therapeut has returned 60.82% as of today's recent price of $50.90.

MRTX : 55.05 (+7.94%)
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a stock index of top companies developing...

CLDX : 0.52 (+1.96%)
JNCE : 7.57 (-2.70%)
IDRA : 0.86 (-1.15%)
RCUS : 11.46 (-5.21%)
BLCM : 7.41 (-2.24%)
INO : 4.32 (unch)
FATE : 10.82 (-2.35%)
MRTX : 55.05 (+7.94%)
SRNE : 6.13 (-9.85%)
MOR : 35.33 (+4.25%)
AGEN : 2.12 (-5.36%)
INCY : 69.20 (-1.30%)
ZYME : 13.19 (-5.45%)
NK : 3.29 (-3.80%)
PIRS : 5.83 (+2.46%)
NLNK : 4.67 (+2.41%)
Should PowerShares DWA SmallCap Momentum Portfolio (DWAS) Be on Your Investing Radar?

Style Box ETF report for DWAS

AXGN : 55.00 (-0.36%)
DWAS : 56.63 (-0.42%)
NEOG : 82.11 (+0.39%)
MRTX : 55.05 (+7.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade MRTX with:

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

2nd Resistance Point 62.12
1st Resistance Point 58.58
Last Price 55.05
1st Support Level 51.21
2nd Support Level 47.37

See More

52-Week High 58.28
Last Price 55.05
Fibonacci 61.8% 37.71
Fibonacci 50% 31.36
Fibonacci 38.2% 25.01
52-Week Low 4.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar